Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia.

IF 7.9 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-09-18 DOI:10.3324/haematol.2025.288178

Kathelijn Verdeyen,Tom Reuvekamp,Walter J F M Van der Velden,Bas J Wouters,Peter A Von dem Borne,Anna Van Rhenen,Birgit I Lissenberg-Witte,Daniëlle Van Lammeren,Geerte L Van Sluis,Eva De Jongh,Roel B Fiets,Maarten F Corsten,Arie C Van der Spek,Anke M Gerrits,Esther R Van Bladel,Lidwine W Tick,Okke De Weerdt,Bregje Van Zaane,Marjan J Cruijsen,Eduardus F M Posthuma,Catharina H M J Van Elssen,Saskia K Klein,Arjan A Van de Loosdrecht,David C De Leeuw

引用次数: 0

Abstract

Not available.

查看原文本刊更多论文

Venetoclax联合低甲基化药物作为复发/难治性急性髓性白血病移植或供体淋巴细胞输注的桥梁。

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.